SynopsisThe global market for Antibiotic Impregnated Catheters was valued at US$ 608 million in the year 2024 and is projected to reach a revised size of US$ 1240 million by 2031, growing at a CAGR of 10.7% during the forecast period. Antibiotic Impregnated Cath.....
SynopsisThe global market for Levonorgestrel was valued at US$ 51.2 million in the year 2024 and is projected to reach a revised size of US$ 64.1 million by 2031, growing at a CAGR of 3.3% during the forecast period. Levonorgestrel is a hormonal medication which.....
SynopsisThe global market for Hybrid Operating Rooms was valued at US$ 4970 million in the year 2024 and is projected to reach a revised size of US$ 7240 million by 2031, growing at a CAGR of 5.6% during the forecast period. A hybrid operating room is an OR equi.....
SynopsisThe global market for Rydapt was valued at US$ 545 million in the year 2024 and is projected to reach a revised size of US$ 2082 million by 2031, growing at a CAGR of 21.4% during the forecast period. Rydapt is a multi-targeted protein kinase inhibitor t.....
SynopsisThe global market for Nausea And Vomiting Treatment was valued at US$ 5887 million in the year 2024 and is projected to reach a revised size of US$ 9093 million by 2031, growing at a CAGR of 6.5% during the forecast period. Nausea and Vomiting Treatment .....
SynopsisThe global market for Chiba Biopsy Needles was valued at US$ 280 million in the year 2024 and is projected to reach a revised size of US$ 429 million by 2031, growing at a CAGR of 6.3% during the forecast period. Fine Needle Aspiration Biopsy Needles (FN.....
SynopsisThe global market for Transcriptomics was valued at US$ 4561 million in the year 2024 and is projected to reach a revised size of US$ 8808 million by 2031, growing at a CAGR of 10.0% during the forecast period. Transcriptomic incorporates the exploration.....
SynopsisThe global market for Chain Pharmacy Prescription Drugs was valued at US$ 35000 million in the year 2024 and is projected to reach a revised size of US$ 40370 million by 2031, growing at a CAGR of 2.1% during the forecast period. Prescription drugs play .....
SynopsisThe global market for Induced Pluripotent Stem Cells (iPSCs) was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 285 million by 2031, growing at a CAGR of 12.3% during the forecast period. Induced pluripotent st.....
SynopsisThe global market for Low Vision Aids was valued at US$ 553 million in the year 2024 and is projected to reach a revised size of US$ 849 million by 2031, growing at a CAGR of 6.4% during the forecast period. Low vision is a term used to describe the visu.....
